We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
We really appreciate the input and it must be so frustrating for the BOD to see their hard work reflected in a somewhat disappointing share price. That said, those who are invested in every sense, I’m sure, will be rewarded in time. The company has so many facets and the opportunities for near term growth are there. et patientes estote autem propriam mercedem accipiet
It was 1 MM vs 2 MMs and now 2 v1 so a little more buying and could go higher.
Given this year will not include Covid revenue hitting £3m H2 so £4m FY is superb. If they expected to exceed £4m I am sure rather than saying the recent wins underpin the forecast they’d say they expect to exceed expectations by 10% for instance. Either way £4m will be superb and remember these Labskin agreements are multi-year and recurring. The recent 3 new client wins were initially for 3 months but all going well I’m sure they’ll enter into the longer term contracts which should mean around £200k/client pa. Sure there will be more wins too and remember China is changing its regs and we are on there and I’m sure will be winning contracts there for labskin next year.
Then we have Covid plays and low hanging fruit in retrofitting existing MWG units. With MWG coming into DVRG I am hoping next year’s revenue is closer to £15m than £10m.
Anyway, let’s hit £4m FY20 and have an update on Covid plays on the coming weeks and hopefully what the broad plan is for the MWG integration. Remember although they have offices in China (good for Labskin too) and recently sent new units and reagents there they are also doing well in India with AMBC. Water scarcity/cleaning/reusing will be more and more on radars as well as monitoring.
I think we'll be £5M for 2020 and probably £20M plus for 2021 Retire
From lse-
Remember -
2017 - £274k
2018 - £500k
2019 - £1m
2020 - £4m forecast
The 2020 is without any Covid revenue and I imagine the larger group will be over £10m 2021 as surely another double up next year for SKIN so £8m and £2m for MWG.
That said with real-time water monitoring and breathalyser I expect DVRG revenues to be well over £10m as if the combined two will be sold as an end to end solution to cruise cos, resorts and much more. Even post Covid they can be used for other pathogens etc.
The share price is frustrating as hell but I imagine come Q1 with some positive RNSs we will be nearer to 100p than 50p.
I appreciate your message I personally bought in right at the top so I'm well under water but I still feel confident for the long-term,if the company keeps progressing then eventually the market will catch up.im not sure I would top just yet though it seems the daily 5percent drops are set to continue short-term .
@Paulcon62, I get that and it is no different to when the share price was just below 2p in March and then went to 0.83p . Building a business takes time and the same for wealth. Nobody like to nurse paper losses, let alone having to sell at a loss. There is a mountain of research in the market on RNS, many good (private) analysts have given of their time and research to allow private investors to do their research and with the facts matching the promises the last 2 years have been positive for those who came in early. Those who came in recently I hope realise that management and staff are aligned to shareholder and have every incentive to ensure that shareholders benefit from long term participation. Time is all we have.
I have seen some frustration on share price and as a large shareholder in both DeepVerge and Modern Water (where I get paid in shares) I have to remind those who are looking at this in the longer term of what your investment is in.
FY 2019 revenue £823,000 (12months)
H1 2020 revenue £1,004,000 (6 months)
FY 2020 guidance - organic growth - £4m (£3m in 6 months)
Gross Margins 78%
May 2019: Acquisition of Rinocloud for £3m
Dec 2019: £1.38m Placing at 1.5p
Jul 2020: £3 million funding facility over 3-years
Jul 2020: £1.5 million initial drawdown
Sept 2020: Additional cash available from warrants exercised £1.1m
Sept 2020: First COVID19 detection agreement for Detroit MI and Fresh Water in Great Lakes, USA, in 3-year Great Lakes water contamination detection Project.
Deployment of Microtox® PD and Microtox® BT Novel Sensors for identification of pathogenic viruses including SARS-CoV-2
Oct 2020: Four new Labskin contracts with global companies (£190k this Qtr)
Nov 2020: All Share acquisition of Modern Water plc value £13m representing 34% of enlarged entity (at today's share price)
All the news to come from all the work being done right now.